Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLS | O94925 | 4/20 | 0.42 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8805649 | 0.86 | GLS (0.40) | GLSSCD5HDAC1LMNAAVPR1A | |
| SCHEMBL28760119 | 0.85 | SCD5 (0.40) | GLSSCD5IDH1 | |
| SCHEMBL266818 | 0.83 | GLS (0.46) | GLSSCD5LMNANPC1TP53 | |
| SCHEMBL17870942 | 0.83 | GLS (0.46) | GLSSCD5LMNANPC1TP53 | |
| SCHEMBL12333636 | 0.83 | GLS (0.46) | GLSSCD5LMNANPC1TP53 | |
| SCHEMBL579739 | 0.83 | AVPR1A (0.45) | GLSHDAC1AVPR1ASMN1; SMN2 | |
| SCHEMBL5890288 | 0.83 | AVPR1A (0.45) | GLSHDAC1AVPR1ASMN1; SMN2 | |
| SCHEMBL579740 | 0.83 | AVPR1A (0.45) | GLSHDAC1AVPR1ASMN1; SMN2 | |
| SCHEMBL2065159 | 0.82 | GLS (0.43) | GLSSCD5HDAC1LMNANPC1 | |
| SCHEMBL2064441 | 0.82 | GLS (0.43) | GLSSCD5HDAC1LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758327-B1 | PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS | UPJOHN CO (US) | 2003-04-09 | — | — | EP | disclosed |
| US-6169181-B1 | HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY | 2001-01-02 | — | — | US | disclosed |
| US-5852195-A | Pyranone compounds useful to treat retroviral infections | PHARMACIA & UPJOHN COMPANY (US) | 1998-12-22 | — | — | US | disclosed |